The benefit of expanding neoadjuvant therapy in treating breast cancer

neoadjuvant treatment

Dr Rika Pienaar makes the case for neoadjuvant therapy in breast cancer: by giving chemotherapy prior to surgery, the benefit of the treatment can be measured.  The behaviour, not the size, of breast tumours can be assessed in the preoperative setting providing a new dimension and clarity to the traditional approach of breast cancer chemotherapy.

Read more The benefit of expanding neoadjuvant therapy in treating breast cancer